Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

New oral GLP-1RA orforglipron comparable to semaglutide for weight loss

Written by | 22 Apr 2025

Results from the ACHIEVE-1 trial show that treatment with orforglipron was associated with weight loss ranging from 4.7 – 7.9% (4.4 – 7.3 Kg) of body weight in… read more.

New UH study targets early signs of vision loss in diabetic patients

Written by | 21 Aug 2024

A $3.3 million study at the University of Houston College of Optometry will track the health of patients with prediabetes and diabetes to find out who might develop… read more.

Type 2 diabetes with cognitive impairment linked to adverse cardiovascular outcomes

Written by | 7 May 2022

Type 2 diabetes patients with cognitive impairment appear to be at increased risks of stroke, heart attack or death compared with non-diabetic patients. Researchers reported their findings on… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.